Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Novel 5-HT6 antagonists from Korean Research Institute of Chemical Technology

April 6, 2006

Priority review granted to Neurodex NDA in emotional lability

April 5, 2006

Lipocine completes product definition study on LPCN-1029

April 5, 2006

Serono seeks U.S., European approvals for new Rebif formulation

April 4, 2006

Alfresa and Tanabe Seiyaku to comarket modafinil in Japan

April 4, 2006

Approvable letter for Xenazine in Huntington's disease-associated chorea

April 3, 2006

Recent patents report new treatments for depression, anxiety, sleep disorders, etc.

April 3, 2006

Lacosamide has clinically relevant effect in neuropathic pain

April 3, 2006

First clinical trial of gene therapy for muscular dystrophy now under way

April 3, 2006

IND cleared for clinical studies of NIC5-15 for Alzheimer's disease

April 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...